[{"Assets_0_Q3_USD":280523030.0,"CommonStockSharesOutstanding_0_Q3_shares":55247579.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-92927325.0,"NetIncomeLoss_1_Q3_USD":-34862399.0,"NetIncomeLoss_3_Q3_USD":-107139327.0,"StockholdersEquity_0_Q3_USD":226880285.0,"Ticker":"ITCI","CIK":"1567514","name":"INTRA-CELLULAR THERAPIES, INC.","OfficialName":"Intra-Cellular Therapies Inc. Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"5718578003.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20191105"}]